Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation | Scientific Reports
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
PLOS ONE: Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
PDF) Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections
Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Double trouble: A drug for alcoholism can also treat cancer by targeting macrophages | EurekAlert! Science News
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Frontiers | Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications | Oncology
Nature on Twitter: "Research published this week suggests that the alcohol-aversion drug disulfiram (Antabuse) could potentially be repurposed as an anti-cancer drug https://t.co/vebcWCatlF… https://t.co/K7QBAxr9AA"
The Alcohol-Abuse Drug Disulfiram Targets NPL4 to Exert Antitumor Effects | Cancer Discovery
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. - Abstract - Europe PMC
Disulfiram (Antabuse) against Cancer, –Boris Cvek
The combination of disulfiram and copper for cancer treatment - ScienceDirect
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase | Oncogene
Disulfiram modulated ROS–MAPK and NF κ B pathways and targeted breast cancer cells with cancer stem cell-like properties | British Journal of Cancer
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Disulfiram (Tetraethylthiuram disulfide) | Aldehyde Dehydrogenase (ALDH) Inhibitor | MedChemExpress
